Renal Cell Carcinoma: Immunotherapy Before Nephrectomy
Team Discovers Unique Immune Cells in RCC
A Challenging Opportunity
The Patrick C. Walsh Hereditary Prostate Cancer Program
Insights into Aggressive Cancer: Cellular Garbage Strikes and Sneaky Sleepers
Changing the Odds
Discovery May Lead to Expanded Donor Pool for Stem Cell Transplants for Patients with Cancer
Dana-Farber Research Supports FDA Approval of Immunotherapy Drug Given After Surgery for Certain Patients with Kidney Cancer
Venetoclax Shown to Benefit Patients with Waldenström Macroglobulinemia, Including Some Who Relapsed After Previous Therapy
A Domino Chain of Discovery
The PSMA-Targeting Era: A Game-Changer for Men with Prostate Cancer Worldwide
Dana-Farber Cancer Institute Faculty Among World’s Most Highly Cited Researchers
Papers Recount How Research Labs Learned to Work in Four-Part Harmony
Survival Similar for Younger and Older Patients with Metastatic Colorectal Cancer, Study Finds
Immunotherapy May Yield Longer Treatment-Free Survival than Targeted Therapy in Advanced Renal Cell Carcinoma Patients
Showing 496 - 510 of 1035 results
Previous| 1... 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 ...69 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
